| Literature DB >> 34975840 |
Paloma A Harcha1, Tamara López-López2, Adrián G Palacios1, Pablo J Sáez2.
Abstract
The role of Pannexin (PANX) channels during collective and single cell migration is increasingly recognized. Amongst many functions that are relevant to cell migration, here we focus on the role of PANX-mediated adenine nucleotide release and associated autocrine and paracrine signaling. We also summarize the contribution of PANXs with the cytoskeleton, which is also key regulator of cell migration. PANXs, as mechanosensitive ATP releasing channels, provide a unique link between cell migration and purinergic communication. The functional association with several purinergic receptors, together with a plethora of signals that modulate their opening, allows PANX channels to integrate physical and chemical cues during inflammation. Ubiquitously expressed in almost all immune cells, PANX1 opening has been reported in different immunological contexts. Immune activation is the epitome coordination between cell communication and migration, as leukocytes (i.e., T cells, dendritic cells) exchange information while migrating towards the injury site. In the current review, we summarized the contribution of PANX channels during immune cell migration and recruitment; although we also compile the available evidence for non-immune cells (including fibroblasts, keratinocytes, astrocytes, and cancer cells). Finally, we discuss the current evidence of PANX1 and PANX3 channels as a both positive and/or negative regulator in different inflammatory conditions, proposing a general mechanism of these channels contribution during cell migration.Entities:
Keywords: Ca2+ signaling; amoeboid migration; cancer; cell communication; inflammation; leukocytes; mechanotransduction; mesenchymal migration
Mesh:
Substances:
Year: 2021 PMID: 34975840 PMCID: PMC8716617 DOI: 10.3389/fimmu.2021.750480
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Summary of CXs and PANX channels contribution to immune cell migration.
| Cell type | Channel | Channel blockers//receptor inhibitors | P2R, AR | Migratory stimuli | Migration techniques | Ref. |
|---|---|---|---|---|---|---|
|
| ||||||
| BMDCs (m) | CX43 | αGA, CX43 KO | n.e. | CCL21 | 3D chemotaxis in collagen | ( |
| DEC205+ DCs (m) | CX43, CX45 | n.e. | n.e. | BaCl muscle damage |
| ( |
| BMDCs (m) | PANX1 | PANX1 KO// | P2X7 | Extracellular ATP | microchannels, 3D collagen, | ( |
|
| ||||||
| Peritoneal macrophages (m) | PANX1-indep. | PANX1 KO//P2Y2 KO, P2Y12 KO, AR-C69931 MX, 8-SPT, MRS-2179, NF449 | P2Y2, P2Y12 | 2D chemotaxis | 2D chemotaxis | ( |
| Cortical CX3CR1+ microglia (m) | und. | Cbx, FFA//Apyrase, RB2, PPADS, Suramin | P2Y | Laser ablation, extracellular ATP |
| ( |
| Retinal CX3CR1+ microglia (m) | PANX1 | Pbc//Apyrase, Suramin | P2 | AMPA |
| ( |
| Cortical CD68+ microglia (m) | PANX1 | Trovafloxacin | n.e. | Controlled cortical impact |
| ( |
| BV-2 microglia cell line | PANX1 | Trovafloxacin, BBFCF, 10PANX1 | P2 | C5a | Transmigration in transwells | ( |
|
| ||||||
| PBMCs (m) | CX43 | αGA, octanol | n.e. | MCP-1 | Transmigration through endothelial layer | ( |
| PBMCs (h), THP-1 cell line | PANX1? | P2Y6 siRNA, BMSCCR222, PTX, U73122, BAPTA, Apyrase, MRS2578 | P2Y6 | CCL2, fMLP | Transmigration in transwells | ( |
|
| ||||||
| PMNs (m) | PANX1 | Cbx, 10PANX1, P2Y2 KO, DIDS, Suramin | P2Y2 | fMLP | Chemotaxis in 2D release from a pipette | ( |
| PMNs (h), HL-60 cell line | PANX1 | Cbx, 10PANX1//CSC, CGS21680, H89 | A2a | fMLP | Chemotaxis in 2D release from a pipette | ( |
| Lung neutrophils (m) | CX43 | CX43+/-, Gap26 | n.e. | LPS | Counting of | ( |
| HL-60 cell line | CX43 (as neg. reg.) | Gap19, 10PANX1//P2Y1 KO, SB 203580 | P2Y1 | LPS | Chemotaxis in 2D confined under agarose | ( |
| Neutrophils (z.f.) | CX43 | Cbx, CX43 morphans, lyz:cx43DN-T2A-mCherry | n.e. | Laser ablation |
| ( |
|
| ||||||
| Innate lymphoid cells (ILCs) | PANX1 | PANX1 KO | n.e. | House dust mite | No direct effect | ( |
| CD4+ T cells (m) | PANX1 | PANX1 KO | n.e | House dust mite |
| ( |
| CD4+ PMBCs (h) | PANX1 | Cbx, PANX1 KD, 10PANX1//Apyrase, suramin, CCCP | P2X4 | CXCL12 | Chemotaxis in 2D, transmigration in transwells | ( |
| CD4+ splenocytes (m) | PANX1 | PANX1 KO | n.e. | Tissue CXCL12 | Counting of | ( |
| CD4+ T cells (m) | PANX1 | Cbx | P2Y10 | CCL19 | Transmigration in transwells | ( |
| CD3+ cells (m) | PANX1 | Pbc | n.e. | und. | Counting of | ( |
|
| ||||||
| Brain mast cells (m) | CX43, PANX1 | n.e. | n.e. | Amyloid β-Peptide | Cortical recruitment in APPswe/PS1dE9 Alzheimer’s model. | ( |
| HSPCs (m) | PANX1 | 10PANX1 | und. | G-CSF, AMD3100 |
| ( |
2PEF, 2-photon excitation microscopy; aGA, a-glycyrrhetinic acid; AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; BMDCs, Bone-marrow derived DCs; Cbx, Carbenoxolone; HSPCs, hematopoietic stem/progenitor cells; FFA, flufenamic acid; G-CSF, granulocyte colony-stimulating factor; h, human; fMLP, N-formyl-Met-Leu-Phe peptide; KD, knock-down; KO, knock-out; LPS, lipopolysaccharide; LN, lymph node; m, mouse; N.E., not evaluated; oATP, oxidized ATP; PBMCs, peripheral blood mononuclear cells; PTX, Pertussis toxin; PMNs, Polymorphonuclear cells; Pbc, Probenecid; und., undetermined; z.f., zebra fish.
Figure 1Regulation of immune cell migration by PANX1 channels. Redistribution of surface PANX1channels have been described during migration of immune cells. (A) In neutrophils after FMLP gradient sensing, opening of PANX1 channels polarize towards the leading edge (right side of the cell) allowing ATP release, subsequently activating local purinergic P2Y2 and -upon ATP degradation- adenosine A3 receptors. Then, at the rear of the migrating cell, activation of the adenosine A2a receptors by adenosine (Ado) promotes inhibitory cascades mediated by cAMP/PKA, leading to an orchestrated cytoskeleton rearrangement required for migration. (B) In T cells activation of CXCR4 receptor with SDF-1 triggers controlled burst of ATP after PANX1 channels opening, which is accompanied by mitochondria and P2X4 translocation to the leading edge where Ca2+ influx occurs. (C) In DCs, ATP-induced fast migration requires an autocrine feedback loop between PANX1 channels and P2X7 receptor, which triggers Ca2+ influx and subsequent activation of CaMKII, which maintains PANX1 channels opened.
Summary of PANX1 contribution to non-immune cell migration.
| Cell type | PANX1 effect on migration | Channel blockers//receptor inhibitors | P2R | Migratory stimuli | Migration techniques | Ref. |
|---|---|---|---|---|---|---|
| Astrocyte DITNC1 cell line | Increase | BBG, Apyrase | n.e. | Thy-1 | 2D wound healing | ( |
| Cortical astrocytes (m) | Increase | n.e. | n.e. | Thy-1 | 2D wound healing | ( |
| Dermal fibroblasts | No effect | PANX1 KO | n.e. | Wound |
| ( |
| I-10 Leydig tumor cell line | Increase | Cbx, Pbc, PANX1 siRNA, U0126 | n.e. | None | 2D wound healing, transmigration in transwells | ( |
| MDA-LM2 and CN-LM1A breast cancer cells (h) | Increase | 10PANX1, Cbx, Panx1 siRNA | n.e. | None | Counting of | ( |
| BICR-M1Rk breast cancer cells (rt) | Increase | Cytochalasin B | n.e. | None | 2D random migration | ( |
| hTCEpi corneal epithelial cells (h) | Increase | 10PANX1, BBG, NF157, Suramin, Apyrase, PPADS | P2X, P2Y | Electric field | 2D galvanotaxis | ( |
| N2a cells, neuroblastoma (m) | Increase | PANX1 siRNA | n.e. | Wound | 2D wound healing | ( |
| Rh18 eRMS, Rh30 aRMS cell line | Overexp. decrease migration | PANX1 loss of function mutants, AHNAK siRNA | n.e. | Wound | 2D wound healing, 3D spheroid growth, | ( |
| C6 glioma cells (rt) | Overexp. decrease migration | n.e. | n.e. | None | Transmigration in transwells, 3D spheroid growth | ( |
| Keratinocytes from neonatal skin (m) | decrease | PANX1 KO | n.e. | Wound |
| ( |
| HDF (h), MDF (m) | decrease | Pbc, 10PANX1, | P2X7 | Wound | 2D wound healing | ( |
| PANX3 effect on migration | ||||||
| HDF (h) | decrease | PANX3 siRNA | P2X7 | Wound | 2D wound healing | ( |
| Increase | n.e. | Wound |
| ( | ||
| HaCaT keratinocyte (h) | Increase | PANX3 siRNA | n.e. | TFG-ß1 | Transmigration in transwells | ( |
aRMS, Alveolar rhabdomyosarcoma; BBG, Brilliant blue G; eRMS, embryonal rhabdomyosarcoma; h, human; HDFs, human dermal fibroblasts; m, mouse; MDFs, murine dermal fibroblasts; Overexp, Overexpression; rt, rat.
Figure 3Proposed model for PANX1 channel regulation of cell migration. PANX1 channels act as positive or negative regulators of cell migration, despite the fact that some pathways and proteins are shared by those opposite responses. We propose that different outcomes are likely to occur due difference in Ca2+ and/or purinergic signaling (i.e. agonists, concentrations, etc). In particular, for Ca2+ signaling, the local (microdomain, nanodomain) regulation of it might activate different signaling cascades leading to increase or decrease of cell migration. In addition, the decoding of Ca2+ signals by Ca2+-sensitive enzymes (i.e. CaMKII) could directly modify the opening of PANX1, leading to changes in cytoskeleton dynamics directly or indirectly (i.e. cytoskeleton -Cytosk.- regulators) will result in signaling cascades that promote or inhibit cell migration. Therefore, the main contribution of PANX1 channels would be to amplify the initial response, and this would be downstream of the intrinsic cell-type specific Ca2+ response that ultimately determines the migratory outcome.
Figure 2Role of PANX1 channels in mesenchymal cell migration. Intracellular regulation of PANX1 channels during migration of mesenchymal non-immune cells is described as a positive or negative regulation, here we summarize the positive regulation. (1) Increased cell migration is correlated with PANX1 overexpression via activation of ERK1/2 pathway, which could also play a major role during collective cell migration (not included in this figure). (2) Thy1/CD90, a surface protein expressed in normal cells, but overexpressed in certain pathologies, interacts with αVβ3-containing integrin and Syndecan 4, which promotes cell migration. The downstream signaling involves focal adhesion kinase (FAK) activation, PI3K, PLCγ and IP3 production, leading to Ca2+ release from intracellular stores, and opening of both CX43 and PANX1 channels. The latter promotes extracellular ATP release and subsequent P2X7 activation, Ca2+ influx and PKCα activation leading to Rac1 activation and RhoA inhibition. (3) Mechanical deformation during transepithelial migration lead to PANX1 channel activation, releasing ATP and activation of P2X7 receptors, leading to cell death by caspase 3/7 activation. Alternatively, PANX1 mutations that change its function lead to P2Y activation, preventing caspase activation and cell death.